{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:50:14Z","timestamp":1782215414933,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48872-x","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:16:09Z","timestamp":1777281369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nationwide seroprevalence study of hepatitis B and hepatitis C viruses among blood donors in Paraguay"],"prefix":"10.1038","volume":"16","author":[{"given":"Federico A.","family":"Di Lello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia P.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz Carolina","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Carolina","family":"Molas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Mercedes","family":"Elizalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo P.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Mart\u00edn","family":"Flichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"8","key":"48872_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu, Y. C., Huang, D. Q. & Nguyen, M. H. Global burden of hepatitis B virus: Current status, missed opportunities and a call for action. Nat. Rev. Gastroenterol. Hepatol. 20 (8), 524\u2013537. https:\/\/doi.org\/10.1038\/s41575-023-00760-9 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"48872_CR2","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/liv.14222","volume":"39","author":"SE Schr\u00f6eder","year":"2019","unstructured":"Schr\u00f6eder, S. E. et al. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series. Liver Int. 39 (10), 1818\u20131836. https:\/\/doi.org\/10.1111\/liv.14222 (2019).","journal-title":"Liver Int."},{"key":"48872_CR3","unstructured":"https:\/\/www.ine.gov.py\/censo2022\/"},{"key":"48872_CR4","unstructured":"https:\/\/www.ine.gov.py\/noticias\/2464\/paraguay-se-encuentra-en-su-mejor-momento-demografico-6-de-cada-10-personas-se-encuentran-en-edad-de-trabajar"},{"key":"48872_CR5","unstructured":"Plan Estrat\u00e9gico nacional (PEN). de la respuesta al VIH\/Sida y otras ITS 2019\u20132023. https:\/\/www.mspbs.gov.py\/dependencias\/pronasida\/adjunto\/a291c2-PENVIH201920231187832.pdf. Accessed October 30."},{"issue":"29","key":"48872_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.15585\/mmwr.mm7329a3","volume":"73","author":"MM Alleman","year":"2024","unstructured":"Alleman, M. M. et al. Progress toward elimination of mother-to-child transmission of hepatitis B Virus - region of the Americas, 2012\u20132022. MMWR Morb Mortal. Wkly. Rep. 73 (29), 648\u2013655. https:\/\/doi.org\/10.15585\/mmwr.mm7329a3 (2024).","journal-title":"MMWR Morb Mortal. Wkly. Rep."},{"issue":"1","key":"48872_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12889-017-4227-6","volume":"17","author":"AM Ropero \u00c1lvarez","year":"2017","unstructured":"Ropero \u00c1lvarez, A. M. et al. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas. BMC Public. Health. 17 (1), 325. https:\/\/doi.org\/10.1186\/s12889-017-4227-6 (2017).","journal-title":"BMC Public. Health"},{"key":"48872_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fpubh.2020.00424","volume":"8","author":"I Sperle","year":"2020","unstructured":"Sperle, I. et al. Prevalence of hepatitis B, C, and D in Germany: Results From a scoping review. Front. Public. Health. 8, 424. https:\/\/doi.org\/10.3389\/fpubh.2020.00424 (2020).","journal-title":"Front. Public. Health"},{"key":"48872_CR9","unstructured":"Indicadores b\u00e1sicos 2019. Tendencias de la salud en las Am\u00e9ricas. https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/52966\/9789275121719_eng.pdf. Accessed October 30."},{"key":"48872_CR10","unstructured":"WHO Library Cataloguing-in-Publication. Data screening donated blood for transfusion-transmissible infections: Recommendations. https:\/\/iris.who.int\/bitstream\/handle\/10665\/44202\/9789241547888_eng.pdf?sequence=1. Accessed October 30."},{"key":"48872_CR11","unstructured":"https:\/\/informacionpublica.paraguay.gov.py\/public\/720884-ESTANDARESDETRABAJODELPNSPARAGUAYPDFpdf-ESTANDARESDETRABAJODELPNSPARAGUAYPDF.pdf"},{"issue":"2","key":"48872_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tmrv.2020.02.001","volume":"34","author":"RY Dodd","year":"2020","unstructured":"Dodd, R. Y. et al. Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10 Year trends in prevalence, incidence, and residual risk, 2007 to 2016. Transfus. Med. Rev. 34 (2), 81\u201393. https:\/\/doi.org\/10.1016\/j.tmrv.2020.02.001 (2020).","journal-title":"Transfus. Med. Rev."},{"issue":"3","key":"48872_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.18004\/MEM.IICS\/1812-9528\/2015.013(03)96-102","volume":"13","author":"GB Olmedo","year":"2015","unstructured":"Olmedo, G. B. et al. Seroreactivity against the hepatitis B virus surface antigen in women who attended the central public health laboratory. Asunci\u00f3n. Paraguay Mem. Inst. Investig Cienc. Salud. 13 (3), 96\u2013102. https:\/\/doi.org\/10.18004\/MEM.IICS\/1812-9528\/2015.013(03)96-102 (2015).","journal-title":"Paraguay Mem. Inst. Investig Cienc. Salud"},{"issue":"1","key":"48872_CR14","first-page":"20","volume":"7","author":"C Rovira","year":"2009","unstructured":"Rovira, C. et al. Prevalence of serologic markers for viral hepatitis in a selected population. Experience of a university service. Years 2000\u20132007. Mem. Inst. Investig Cienc. Salud. 7 (1), 20\u201326 (2009).","journal-title":"Mem. Inst. Investig Cienc. Salud"},{"issue":"1","key":"48872_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18004\/rvspmi\/2312-3893\/2021.08.01.85","volume":"8","author":"MN Escobar Amarilla","year":"2021","unstructured":"Escobar Amarilla, M. N., Montiel, C. R. & Galeano, I. O. Reactive serologies in donors from the Blood Bank of the Hospital de Cl\u00ednicas. Paraguay Rev. Virtual Soc. Parag Med. Int. 8 (1), 85\u201393. https:\/\/doi.org\/10.18004\/rvspmi\/2312-3893\/2021.08.01.85 (2021).","journal-title":"Paraguay Rev. virtual Soc. Parag Med. Int."},{"issue":"1","key":"48872_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12879-024-09753-8","volume":"24","author":"L Wei","year":"2024","unstructured":"Wei, L. et al. Analysis of hepatitis B Virus test results among blood donors in Chongqing, China. BMC Infect. Dis. 24 (1), 857. https:\/\/doi.org\/10.1186\/s12879-024-09753-8 (2024).","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"48872_CR17","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/v14071504","volume":"14","author":"C Saitta","year":"2022","unstructured":"Saitta, C., Pollicino, T., Raimondo, G. & Occult Hepatitis, B. Virus Infection: An Update. Viruses 14 (7), 1504. https:\/\/doi.org\/10.3390\/v14071504 (2022).","journal-title":"Viruses"},{"issue":"11","key":"48872_CR18","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1111\/trf.18094","volume":"64","author":"MX Fu","year":"2024","unstructured":"Fu, M. X. et al. Virology subgroup of the ISBT WP-TTID. International review of blood donation screening for anti-HBc and occult hepatitis B virus infection. Transfusion 64 (11), 2144\u20132156. https:\/\/doi.org\/10.1111\/trf.18094 (2024).","journal-title":"Transfusion"},{"issue":"6","key":"48872_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000525480","volume":"49","author":"A Zbinden","year":"2022","unstructured":"Zbinden, A. et al. Prevalence of occult hepatitis B Virus infection in blood donors with negative ID-NAT in Switzerland. Transfus. Med. Hemother. 49 (6), 338\u2013345. https:\/\/doi.org\/10.1159\/000525480 (2022).","journal-title":"Transfus. Med. Hemother"},{"issue":"4","key":"48872_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/diagnostics15040486","volume":"15","author":"AS Alshrari","year":"2025","unstructured":"Alshrari, A. S. et al. Prevalence and transfusion risks of occult hepatitis B infection among HBcAb-Positive blood donors in a high-endemic region. Diagnostics (Basel). 15 (4), 486. https:\/\/doi.org\/10.3390\/diagnostics15040486 (2025).","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"48872_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41598-024-53273-z","volume":"14","author":"C Wang","year":"2024","unstructured":"Wang, C., Li, X., Zhang, C., Xiao, L. & Xian, J. Prevalence and influential factors of isolated hepatitis B core antibody positivity in a Chinese adult population. Sci. Rep. 14 (1), 693. https:\/\/doi.org\/10.1038\/s41598-024-53273-z (2024).","journal-title":"Sci. Rep."},{"issue":"30","key":"48872_CR22","doi-asserted-by":"publisher","first-page":"2200837","DOI":"10.2807\/1560-7917.ES.2023.28.30.2200837","volume":"28","author":"N Khetsuriani","year":"2023","unstructured":"Khetsuriani, N. et al. Toward reaching hepatitis B goals: Hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021. Euro. Surveill. 28 (30), 2200837. (2023).","journal-title":"Euro. Surveill"},{"issue":"3","key":"48872_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/medicina60030436","volume":"60","author":"S Raj\u010devi\u0107","year":"2024","unstructured":"Raj\u010devi\u0107, S. et al. Seroprevalence study of Anti-HBs antibodies in the general population of Vojvodina. Serbia Med. 60 (3), 436. https:\/\/doi.org\/10.3390\/medicina60030436 (2024).","journal-title":"Serbia Med."},{"key":"48872_CR24","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/microorganisms12071368","volume":"12","author":"M Campos-Valdez","year":"2024","unstructured":"Campos-Valdez, M., Castro-Garc\u00eda, M. A., Ramos-M\u00e1rquez, M. E., Gurrola-D\u00edaz, C. M. & Salazar-Montes, A. M. S\u00e1nchez-Orozco L.V. An update on viral hepatitis B and C in Mexico: Advances and Pitfalls in Eradication strategies. Microorganisms 12, 1368. https:\/\/doi.org\/10.3390\/microorganisms12071368 (2024).","journal-title":"Microorganisms"},{"key":"48872_CR25","doi-asserted-by":"publisher","first-page":"13986","DOI":"10.1038\/s41598-021-93434-y","volume":"11","author":"CS Pinto","year":"2021","unstructured":"Pinto, C. S. et al. Clinical, epidemiological aspects, and trends of Hepatitis B in Brazil from 2007 to 2018. Sci. Rep. 11, 13986. https:\/\/doi.org\/10.1038\/s41598-021-93434-y (2021).","journal-title":"Sci. Rep."},{"issue":"3","key":"48872_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11938-022-00382-1","volume":"20","author":"LA D\u00edaz","year":"2022","unstructured":"D\u00edaz, L. A. et al. Liver diseases in Latin America: Current Status, unmet needs, and opportunities for improvement. Curr. Treat. Options Gastroenterol. 20 (3), 261\u2013278. https:\/\/doi.org\/10.1007\/s11938-022-00382-1 (2022).","journal-title":"Curr. Treat. Options Gastroenterol."},{"issue":"2","key":"48872_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/cld.1084","volume":"18","author":"JP Roblero","year":"2021","unstructured":"Roblero, J. P., Arab, J. P., Mezzano, G., Mendizabal, M. & Hepatitis, C. Virus infection: What are we currently doing in latin America About WHO\u2019s proposals for 2030? Clin. Liver Dis. 18 (2), 72\u201375. https:\/\/doi.org\/10.1002\/cld.1084 (2021).","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"48872_CR28","first-page":"5","volume":"3","author":"C Rovira","year":"2005","unstructured":"Rovira, C., Monz\u00f3n, M. I., Ben\u00edtez, A. & Azorero, M. Viral hepatitis in different ethnic groups of Paraguay. Mem. Inst. Invest. Cienc. Salud. 3 (1), 5\u20138 (2005).","journal-title":"Mem. Inst. Invest. Cienc. Salud"},{"issue":"RR-4","key":"48872_CR29","first-page":"1","volume":"61","author":"BD Smith","year":"2012","unstructured":"Smith, B. D. et al. Centers for disease control and prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965. MMWR Recomm Rep. 61 (RR-4), 1\u201332 (2012).","journal-title":"MMWR Recomm Rep."},{"issue":"2","key":"48872_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10096-017-3123-4","volume":"37","author":"K Neukam","year":"2018","unstructured":"Neukam, K. et al. Prevalence of hepatitis C virus infection according to the year of birth: Identification of risk groups. Eur. J. Clin. Microbiol. Infect. Dis. 37 (2), 247\u2013254. https:\/\/doi.org\/10.1007\/s10096-017-3123-4 (2018).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"30","key":"48872_CR31","doi-asserted-by":"publisher","first-page":"2300651","DOI":"10.2807\/1560-7917.ES.2024.29.30.2300651","volume":"29","author":"M Hleyhel","year":"2024","unstructured":"Hleyhel, M. et al. Prevalence of chronic hepatitis C infection in the general population: Results from a national survey, Estonia, July to December 2022. Euro. Surveill. 29 (30), 2300651. (2024).","journal-title":"Euro. Surveill"},{"issue":"1","key":"48872_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jiph.2018.08.003","volume":"12","author":"KJ Moore","year":"2019","unstructured":"Moore, K. J., Gauri, A. & Koru-Sengul, T. Prevalence and sociodemographic disparities of Hepatitis C in Baby Boomers and the US adult population. J. Infect. Public. Health. 12 (1), 32\u201336. https:\/\/doi.org\/10.1016\/j.jiph.2018.08.003 (2019).","journal-title":"J. Infect. Public. Health"},{"issue":"2","key":"48872_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/v15020314","volume":"15","author":"RQ Ferrufino","year":"2023","unstructured":"Ferrufino, R. Q. et al. Factors associated with spontaneous clearance of recently acquired hepatitis C Virus among HIV-positive men in Brazil. Viruses 15 (2), 314. https:\/\/doi.org\/10.3390\/v15020314 (2023).","journal-title":"Viruses"},{"key":"48872_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cca.2019.08.002","volume":"498","author":"J Ha","year":"2019","unstructured":"Ha, J., Park, Y. & Kim, H. S. Signal-to-cutoff ratios of current anti-HCV assays and a suggestion of new algorithm of supplementary testing. Clin. Chim. Acta. 498, 11\u201315. https:\/\/doi.org\/10.1016\/j.cca.2019.08.002 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"48872_CR35","doi-asserted-by":"publisher","first-page":"8689","DOI":"10.1038\/s41598-021-88138-2","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations. Sci. Rep. 11, 8689. https:\/\/doi.org\/10.1038\/s41598-021-88138-2 (2021).","journal-title":"Sci. Rep."},{"key":"48872_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S2468-1253(24)00442-4","volume":"10","author":"A Artenie","year":"2025","unstructured":"Artenie, A. et al. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: A multi-stage analysis. Lancet Gastroenterol. Hepatol. 10, 315\u2013331. https:\/\/doi.org\/10.1016\/S2468-1253(24)00442-4 (2025).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"48872_CR37","doi-asserted-by":"publisher","first-page":"e70117","DOI":"10.1002\/rmv.70117","volume":"36","author":"HS Madeira","year":"2026","unstructured":"Madeira, H. S. et al. Improved safety of nucleic acid amplification technology combined with serological tests for screening blood donors: A Systematic review and meta-analysis. Rev. Med. Virol. 36, e70117. https:\/\/doi.org\/10.1002\/rmv.70117 (2026).","journal-title":"Rev. Med. Virol."},{"key":"48872_CR38","doi-asserted-by":"publisher","first-page":"115033","DOI":"10.1016\/j.diagmicrobio.2020.115033","volume":"97","author":"E Sickinger","year":"2020","unstructured":"Sickinger, E. et al. Performance characteristics of the high sensitivity Alinity i & Architect HBsAg next qualitative\/confirmatory assays. Diagn. Microbiol. Infect. Dis. 97, 115033. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115033 (2020).","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48872-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:07:57Z","timestamp":1782212877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48872-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48872"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48872-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8071757\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the School of Pharmacy and Biochemistry, University of Buenos Aires (EX-2022-01463207- -UBA-DME#SSA_FFYB). During the study period, informed consent was obtained from all donors. The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"19394"}}